世界の光医学市場2020年-2030年:技術別(レーザー、多色偏光、フルスペクトルライト、ダイクロイックランプ、発光ダイオード、蛍光灯)、用途別

【英語タイトル】Photomedicine Market By Technology (Lasers, Polychromatic Polarized Light, Full Spectrum Light, Dichroic Lamps, Light Emitting Diodes, Fluorescent Lamps), By Application (Dermatology, Pain Management, Oncology, Ophthalmology, Wound Healing, Dental Procedures, Aesthetics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Allied Market Researchが出版した調査資料(ALD22AU226)・商品コード:ALD22AU226
・発行会社(調査会社):Allied Market Research
・発行日:2022年3月
・ページ数:151
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,540 ⇒換算¥819,920見積依頼/購入/質問フォーム
5 UserUSD6,654 ⇒換算¥984,792見積依頼/購入/質問フォーム
Enterprise UserUSD10,280 ⇒換算¥1,521,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社は、2020年に4,048百万ドルであった世界の光医学市場が、2021年から2030年まで年平均6.7%成長し、2030年までに7,510 百万ドルに達すると予測しています。当書では、光医学の世界市場を対象に総合的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、技術別(レーザー、多色偏光、フルスペクトルライト、ダイクロイックランプ、その他)分析、用途別(皮膚科、疼痛管理、腫瘍、眼科、その他)分析、地域別分析、企業状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Baring Private Equity Asia Limited、AngioDynamics, Inc.、Apax Partners Llp、Biomedical Technology Holdings Limited、Colorado Skin and Vein、johnson and johnson md&d、PhotoMedex, Inc.、Koninklijke Philips N.V.、Sisram Medical Ltd.、Thor Photomedicine Ltd.などが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の光医学市場規模:技術別(レーザー、多色偏光、フルスペクトルライト、ダイクロイックランプ、その他)
・世界の光医学市場規模:用途別(皮膚科、疼痛管理、腫瘍、眼科、その他)
・世界の光医学市場規模:地域別
・企業状況
・企業情報

The global photomedicine market was valued at $4,048 million in 2020, and is estimated to reach $7,510 million by 2030, growing at a CAGR of 6.7% from 2021 to 2030.
 
Photomedicine is an interdisciplinary branch of science that involves the study of light and its therapeutic application in various healthcare fields. In this technology, the disease can be detected and treated by exposing the damaged area to light with specific wavelengths. Various wavelengths of light, such as blue, red, and near-infrared have a different effect on the body and are used to treat different diseases. Various light sources, such as LED and laser help to effectively and non-invasively treat the disease. As these procedures are minimally invasive, they do not leave a visible scar and the procedure is completed in a short time.
 
Advantages of using photomedicine devices, such as painless procedure and shorter length of hospital stay, have increased awareness about this technology. Phototherapy using different light sources, such as polychromatic polarized light and full spectrum light is used in the treatment of various skin and eye diseases. As photomedicine procedures are effective and minimally invasive, there is a rise in the adoption rate of photomedicine devices. Moreover, they are increasingly being used for aesthetic procedures, such as tattoo and unwanted hair removal.
 
This market is majorly driven by increase in demand by the consumer of aesthetic enhancement, which mainly comprise of minimally invasive procedures. Technological advancement in laser guided procedures for hair removal, tattoo removal, and skin resurfacing, especially in women, for beautification is on the rise. The youth and elderly are becoming more conscious of the importance of beauty and well-being. The elderly wish to look younger, which is accomplished by the use of aesthetic-enhancing operations. Photomedicine products are in high demand because they provide less invasive and effective cosmetic operations.
For instance, in October 2020, Alma Laser, one of the leading companies in the photomedicine market and a subsidiary of Sisram Medical, launched the Alma Hybrid platform, which comprises of CO2 laser, 1570nm laser, and IMPACT for trans-epidermal delivery for skin rejuvenation. Thus, launch of such products by key market players further boosts the market growth.
Market players have invested in various developing photomedicine products that aid in ophthalmological, wound healing, pain management, and wide range of dental procedures treatments. Moreover, rise in vision problems due excessive screen time on mobile and computer demand for lasik surgeries, which further drives the market growth.
Photomedicine products, such as the THOR Small LED Cluster, THOR Medium LED Cluster is used for wound healing and superficial musculoskeletal injuries. Similarly, THOR NIR Dental Laser is used for analgesia, deep anti-inflammatory & deep tissue repair. Alma Laser offers Soprano ICE Platinum based on trio clustered diode technology for hair removal. Thus, increase in availability of wide range of products increases the accessibility for the population and significantly drives the market growth.
However, availability of alternative treatment methods and product safety issues of photomedicine devices are expected to restrain the growth of the market. Conversely, presence of a plethora of products in the pipeline and high market potential in untapped emerging economies are anticipated to serve as attractive opportunities for the market growth during the forecast period.
 
The photomedicine market is segmented into technology, application, and region. On the basis of technology, it is classified into lasers, polychromatic polarized light, full spectrum light, dichroic lamps, light emitting diodes, and fluorescent lamps. On the basis of applications, it is segmented into dermatology, pain management, oncology, ophthalmology, wound healing, dental procedures, aesthetics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, Middle East, and Africa (LAMEA).
The major players profiled in the report are Baring Private Equity Asia Limited (Lumenis Ltd.), Angiodynamics, Inc., Apax Partners LLP. (Syneron Medical Ltd.), Biomedical Technology Holdings Limited (Biolitec AG), Colorado Skin and Vein, Johnson and Johnson, Koninklijke Philips N.V., PhotoMedex, Inc., Sisram Medical Ltd. (Alma Lasers Ltd.), and Thor Photomedicine Ltd.
 
Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the photomedicine market analysis from 2020 to 2030 to identify the prevailing photomedicine market growth opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the photomedicine market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global photomedicine market size, trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technology
● Lasers
● Polychromatic Polarized Light
● Full Spectrum Light
● Dichroic Lamps
● Light Emitting Diodes
● Fluorescent Lamps

By Application
● Dermatology
● Pain Management
● Oncology
● Ophthalmology
● Wound Healing
● Dental Procedures
● Aesthetics
● Others

By Region
● Europe
○ France
○ Germany
○ U.K.
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ Australia
○ India
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● North America
○ U.S.
○ Canada
○ Mexico

● Key Market Players
○ Baring Private Equity Asia Limited
○ AngioDynamics, Inc.
○ Apax Partners Llp
○ Biomedical Technology Holdings Limited
○ Colorado Skin and Vein
○ johnson and johnson md&d
○ PhotoMedex, Inc.
○ Koninklijke Philips N.V.
○ Sisram Medical Ltd.
○ Thor Photomedicine Ltd.

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PHOTOMEDICINE MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Lasers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Polychromatic Polarized Light
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Full Spectrum Light
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Dichroic Lamps
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Light Emitting Diodes
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Fluorescent Lamps
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: PHOTOMEDICINE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Dermatology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Pain Management
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Oncology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Ophthalmology
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Wound Healing
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Dental Procedures
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Aesthetics
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
5.9 Others
5.9.1 Key market trends, growth factors and opportunities
5.9.2 Market size and forecast, by region
5.9.3 Market analysis by country
CHAPTER 6: PHOTOMEDICINE MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 Europe
6.2.1 Key trends and opportunities
6.2.2 Europe Market size and forecast, by Technology
6.2.3 Europe Market size and forecast, by Application
6.2.4 Europe Market size and forecast, by country
6.2.4.1 France
6.2.4.1.1 Market size and forecast, by Technology
6.2.4.1.2 Market size and forecast, by Application
6.2.4.2 Germany
6.2.4.2.1 Market size and forecast, by Technology
6.2.4.2.2 Market size and forecast, by Application
6.2.4.3 U.K.
6.2.4.3.1 Market size and forecast, by Technology
6.2.4.3.2 Market size and forecast, by Application
6.2.4.4 Italy
6.2.4.4.1 Market size and forecast, by Technology
6.2.4.4.2 Market size and forecast, by Application
6.2.4.5 Spain
6.2.4.5.1 Market size and forecast, by Technology
6.2.4.5.2 Market size and forecast, by Application
6.2.4.6 Rest of Europe
6.2.4.6.1 Market size and forecast, by Technology
6.2.4.6.2 Market size and forecast, by Application
6.3 Asia-Pacific
6.3.1 Key trends and opportunities
6.3.2 Asia-Pacific Market size and forecast, by Technology
6.3.3 Asia-Pacific Market size and forecast, by Application
6.3.4 Asia-Pacific Market size and forecast, by country
6.3.4.1 Japan
6.3.4.1.1 Market size and forecast, by Technology
6.3.4.1.2 Market size and forecast, by Application
6.3.4.2 China
6.3.4.2.1 Market size and forecast, by Technology
6.3.4.2.2 Market size and forecast, by Application
6.3.4.3 Australia
6.3.4.3.1 Market size and forecast, by Technology
6.3.4.3.2 Market size and forecast, by Application
6.3.4.4 India
6.3.4.4.1 Market size and forecast, by Technology
6.3.4.4.2 Market size and forecast, by Application
6.3.4.5 South Korea
6.3.4.5.1 Market size and forecast, by Technology
6.3.4.5.2 Market size and forecast, by Application
6.3.4.6 Rest of Asia-Pacific
6.3.4.6.1 Market size and forecast, by Technology
6.3.4.6.2 Market size and forecast, by Application
6.4 LAMEA
6.4.1 Key trends and opportunities
6.4.2 LAMEA Market size and forecast, by Technology
6.4.3 LAMEA Market size and forecast, by Application
6.4.4 LAMEA Market size and forecast, by country
6.4.4.1 Brazil
6.4.4.1.1 Market size and forecast, by Technology
6.4.4.1.2 Market size and forecast, by Application
6.4.4.2 Saudi Arabia
6.4.4.2.1 Market size and forecast, by Technology
6.4.4.2.2 Market size and forecast, by Application
6.4.4.3 South Africa
6.4.4.3.1 Market size and forecast, by Technology
6.4.4.3.2 Market size and forecast, by Application
6.4.4.4 Rest of LAMEA
6.4.4.4.1 Market size and forecast, by Technology
6.4.4.4.2 Market size and forecast, by Application
6.5 North America
6.5.1 Key trends and opportunities
6.5.2 North America Market size and forecast, by Technology
6.5.3 North America Market size and forecast, by Application
6.5.4 North America Market size and forecast, by country
6.5.4.1 U.S.
6.5.4.1.1 Market size and forecast, by Technology
6.5.4.1.2 Market size and forecast, by Application
6.5.4.2 Canada
6.5.4.2.1 Market size and forecast, by Technology
6.5.4.2.2 Market size and forecast, by Application
6.5.4.3 Mexico
6.5.4.3.1 Market size and forecast, by Technology
6.5.4.3.2 Market size and forecast, by Application
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Baring Private Equity Asia Limited
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 AngioDynamics, Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Apax Partners Llp
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Biomedical Technology Holdings Limited
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Colorado Skin and Vein
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 johnson and johnson md&d
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 PhotoMedex, Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Koninklijke Philips N.V.
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Sisram Medical Ltd.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Thor Photomedicine Ltd.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 2. PHOTOMEDICINE MARKET REVENUE, FOR LASERS, BY REGION , 2020-2030,($MILLION)
TABLE 3. PHOTOMEDICINE MARKET LASERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. PHOTOMEDICINE MARKET REVENUE, FOR POLYCHROMATIC POLARIZED LIGHT, BY REGION , 2020-2030,($MILLION)
TABLE 5. PHOTOMEDICINE MARKET POLYCHROMATIC POLARIZED LIGHT BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. PHOTOMEDICINE MARKET REVENUE, FOR FULL SPECTRUM LIGHT, BY REGION , 2020-2030,($MILLION)
TABLE 7. PHOTOMEDICINE MARKET FULL SPECTRUM LIGHT BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. PHOTOMEDICINE MARKET REVENUE, FOR DICHROIC LAMPS, BY REGION , 2020-2030,($MILLION)
TABLE 9. PHOTOMEDICINE MARKET DICHROIC LAMPS BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. PHOTOMEDICINE MARKET REVENUE, FOR LIGHT EMITTING DIODES, BY REGION , 2020-2030,($MILLION)
TABLE 11. PHOTOMEDICINE MARKET LIGHT EMITTING DIODES BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. PHOTOMEDICINE MARKET REVENUE, FOR FLUORESCENT LAMPS, BY REGION , 2020-2030,($MILLION)
TABLE 13. PHOTOMEDICINE MARKET FLUORESCENT LAMPS BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. GLOBAL PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 15. PHOTOMEDICINE MARKET REVENUE, FOR DERMATOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 16. PHOTOMEDICINE MARKET DERMATOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. PHOTOMEDICINE MARKET REVENUE, FOR PAIN MANAGEMENT, BY REGION , 2020-2030,($MILLION)
TABLE 18. PHOTOMEDICINE MARKET PAIN MANAGEMENT BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. PHOTOMEDICINE MARKET REVENUE, FOR ONCOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 20. PHOTOMEDICINE MARKET ONCOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. PHOTOMEDICINE MARKET REVENUE, FOR OPHTHALMOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 22. PHOTOMEDICINE MARKET OPHTHALMOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. PHOTOMEDICINE MARKET REVENUE, FOR WOUND HEALING, BY REGION , 2020-2030,($MILLION)
TABLE 24. PHOTOMEDICINE MARKET WOUND HEALING BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. PHOTOMEDICINE MARKET REVENUE, FOR DENTAL PROCEDURES, BY REGION , 2020-2030,($MILLION)
TABLE 26. PHOTOMEDICINE MARKET DENTAL PROCEDURES BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. PHOTOMEDICINE MARKET REVENUE, FOR AESTHETICS, BY REGION , 2020-2030,($MILLION)
TABLE 28. PHOTOMEDICINE MARKET AESTHETICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. PHOTOMEDICINE MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 30. PHOTOMEDICINE MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. PHOTOMEDICINE MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 32. EUROPE PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 33. EUROPE PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 34. EUROPE PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 35. FRANCE PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 36. FRANCE PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 37. GERMANY PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 38. GERMANY PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 39. U.K. PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 40. U.K. PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 41. ITALY PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 42. ITALY PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 43. SPAIN PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 44. SPAIN PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 45. REST OF EUROPE PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 46. REST OF EUROPE PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 47. ASIA-PACIFIC PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 48. ASIA-PACIFIC PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 49. ASIA-PACIFIC PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 50. JAPAN PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 51. JAPAN PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 52. CHINA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 53. CHINA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 54. AUSTRALIA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 55. AUSTRALIA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 56. INDIA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 57. INDIA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 58. SOUTH KOREA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 59. SOUTH KOREA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 60. REST OF ASIA-PACIFIC PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 61. REST OF ASIA-PACIFIC PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 62. LAMEA PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 63. LAMEA PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 64. LAMEA PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 65. BRAZIL PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 66. BRAZIL PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 67. SAUDI ARABIA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 68. SAUDI ARABIA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 69. SOUTH AFRICA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 70. SOUTH AFRICA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 71. REST OF LAMEA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 72. REST OF LAMEA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 73. NORTH AMERICA PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 74. NORTH AMERICA PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 75. NORTH AMERICA PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 76. U.S. PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 77. U.S. PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 78. CANADA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 79. CANADA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 80. MEXICO PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 81. MEXICO PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 82.BARING PRIVATE EQUITY ASIA LIMITED: COMPANY SNAPSHOT
TABLE 83.BARING PRIVATE EQUITY ASIA LIMITED: OPERATING SEGMENTS
TABLE 84.BARING PRIVATE EQUITY ASIA LIMITED: PRODUCT PORTFOLIO
TABLE 85.BARING PRIVATE EQUITY ASIA LIMITED: NET SALES,
TABLE 86.BARING PRIVATE EQUITY ASIA LIMITED: KEY STRATERGIES
TABLE 87.ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
TABLE 88.ANGIODYNAMICS, INC.: OPERATING SEGMENTS
TABLE 89.ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO
TABLE 90.ANGIODYNAMICS, INC.: NET SALES,
TABLE 91.ANGIODYNAMICS, INC.: KEY STRATERGIES
TABLE 92.APAX PARTNERS LLP: COMPANY SNAPSHOT
TABLE 93.APAX PARTNERS LLP: OPERATING SEGMENTS
TABLE 94.APAX PARTNERS LLP: PRODUCT PORTFOLIO
TABLE 95.APAX PARTNERS LLP: NET SALES,
TABLE 96.APAX PARTNERS LLP: KEY STRATERGIES
TABLE 97.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: COMPANY SNAPSHOT
TABLE 98.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: OPERATING SEGMENTS
TABLE 99.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: PRODUCT PORTFOLIO
TABLE 100.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: NET SALES,
TABLE 101.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: KEY STRATERGIES
TABLE 102.COLORADO SKIN AND VEIN: COMPANY SNAPSHOT
TABLE 103.COLORADO SKIN AND VEIN: OPERATING SEGMENTS
TABLE 104.COLORADO SKIN AND VEIN: PRODUCT PORTFOLIO
TABLE 105.COLORADO SKIN AND VEIN: NET SALES,
TABLE 106.COLORADO SKIN AND VEIN: KEY STRATERGIES
TABLE 107.JOHNSON AND JOHNSON MD&D: COMPANY SNAPSHOT
TABLE 108.JOHNSON AND JOHNSON MD&D: OPERATING SEGMENTS
TABLE 109.JOHNSON AND JOHNSON MD&D: PRODUCT PORTFOLIO
TABLE 110.JOHNSON AND JOHNSON MD&D: NET SALES,
TABLE 111.JOHNSON AND JOHNSON MD&D: KEY STRATERGIES
TABLE 112.PHOTOMEDEX, INC.: COMPANY SNAPSHOT
TABLE 113.PHOTOMEDEX, INC.: OPERATING SEGMENTS
TABLE 114.PHOTOMEDEX, INC.: PRODUCT PORTFOLIO
TABLE 115.PHOTOMEDEX, INC.: NET SALES,
TABLE 116.PHOTOMEDEX, INC.: KEY STRATERGIES
TABLE 117.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 118.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 119.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 120.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 121.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 122.SISRAM MEDICAL LTD.: COMPANY SNAPSHOT
TABLE 123.SISRAM MEDICAL LTD.: OPERATING SEGMENTS
TABLE 124.SISRAM MEDICAL LTD.: PRODUCT PORTFOLIO
TABLE 125.SISRAM MEDICAL LTD.: NET SALES,
TABLE 126.SISRAM MEDICAL LTD.: KEY STRATERGIES
TABLE 127.THOR PHOTOMEDICINE LTD.: COMPANY SNAPSHOT
TABLE 128.THOR PHOTOMEDICINE LTD.: OPERATING SEGMENTS
TABLE 129.THOR PHOTOMEDICINE LTD.: PRODUCT PORTFOLIO
TABLE 130.THOR PHOTOMEDICINE LTD.: NET SALES,
TABLE 131.THOR PHOTOMEDICINE LTD.: KEY STRATERGIES

★調査レポート[世界の光医学市場2020年-2030年:技術別(レーザー、多色偏光、フルスペクトルライト、ダイクロイックランプ、発光ダイオード、蛍光灯)、用途別] (コード:ALD22AU226)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の光医学市場2020年-2030年:技術別(レーザー、多色偏光、フルスペクトルライト、ダイクロイックランプ、発光ダイオード、蛍光灯)、用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆